Triatec 2.5 mg Sanofi

Triatec is a well-known pharmaceutical product containing the active ingredient Ramipril, an ACE inhibitor used primarily for the treatment of hypertension (high blood pressure) and heart failure. The brand was originally developed by the German pharmaceutical company Hoechst AG, which later became part of Aventis and eventually Sanofi.

Today, the brand is owned and marketed by Sanofi, a French multinational pharmaceutical company headquartered in Paris. Due to Sanofi's global manufacturing footprint, Triatec is produced in multiple locations worldwide, including European facilities in countries like Italy and Germany, as well as sites in other regions to serve local markets. The packaging shown is specifically for the Italian market, as indicated by the text 'compresse' and 'uso orale'.